Karen Costenbader, MD, MPHEnriched profile
Director, Lupus Program; Chief, Section of Clinical Sciences; Michael E. Weinblatt, MD Distinguished Chair in Rheumatology; Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital / Harvard Medical School, Division of Rheumatology, Inflammation and Immunity, Boston, MA
Overview
Updated 14 Jul 2026
Karen H. Costenbader, MD MPH, is Director, Lupus Program at Brigham and Women's Hospital / Harvard Medical School, Division of Rheumatology, Inflammation and Immunity, Boston, MA. The public record shows 473 publications with 42,017 citations (h-index 81), centered on Osteoarthritis, Rheumatoid Arthritis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 9 companies, 8 NIH-funded awards (2005–2026).
- Most recent indexed publication: 2026 · Arthritis & rheumatology (Hoboken, N.J.)
- Top research focus: Osteoarthritis
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 76 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
Sponsor: Brigham and Women's Hospital
InvestigatorCompletedNCT01351805
Industry payments
Updated 14 Jul 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20253 payments
- GlaxoSmithKline, LLC.Program year20253 payments
- UCB SAProgram year20251 payment
NIH funding
Updated 14 Jul 2026
8 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- GENE ENVIRONMENT TRIGGERS AND PROTEOMIC PATHWAYS MEDIATING ANTI-NUCLEAR AUTOIMMUNITY AND SYSTEMIC RHEUMATIC DISEASE
University of Houston
FY2026$667,276R01AR086872 - Dapagliflozin in Active Lupus Nephritis: A Pilot and Feasibility Randomized Trial
Brigham and Women'S Hospital
FY2026$364,560R01DK145763 - Elucidating Social Determinants and Mental Health Needs to Achieve Equity in Rheumatic Disease Care
Brigham and Women'S Hospital
FY2023$358,000R03AR083661
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Testing the Possibility of Preventing Systemic Lupus Erythematosus.
Arthritis & rheumatology (Hoboken, N.J.)
2026 - Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials.
Lupus science & medicine
2026
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
60 Fenwood Road, 2nd Floor, Hale Building for Transformative Medicine, Boston, MA 02115
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- MPH
Harvard T.H. Chan School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Master's degree
University of Cambridge, England
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.org ↗
Editorial & leadership rolesjournal and society appointments
- Deputy Editor
Arthritis & Rheumatology (ACR journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →worldmedicalinnovation.org ↗
Secondary affiliationsappointments beyond the home institution
- Chair
Medical-Scientific Advisory Council, Lupus Foundation of America
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Faculty
Pri-Med (CME provider)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- "Karen Costenbader, MD: Data Supports Belimumab as Treatment in Early Lupus"
HCPLive/Rheumatology Live video interview
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheum-live.com ↗ - COVID-19 impact on lupus patients interview
BWH Lupus Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.bwh.harvard.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/karen-costenbader-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Karen-Costenbader
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/reel/DBwY6wdtXx1
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - X / Twitter
x.com/ACR_Journals
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.